Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Natasha N Naidu"'
Autor:
Shohei Ogata, Chisato Shimizu, Alessandra Franco, Ranim Touma, John T Kanegaye, Biswa P Choudhury, Natasha N Naidu, Yutaka Kanda, Long T Hoang, Martin L Hibberd, Adriana H Tremoulet, Ajit Varki, Jane C Burns
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e81448 (2013)
Although intravenous immunoglobulin (IVIG) is highly effective in Kawasaki disease (KD), mechanisms are not understood and 10-20% of patients are treatment-resistant, manifesting a higher rate of coronary artery aneurysms. Murine models suggest that
Externí odkaz:
https://doaj.org/article/04334d642b0d4bb59dcaa230291a5319
Autor:
Jane C. Burns, Ajit Varki, Shohei Ogata, Ranim Touma, Natasha N. Naidu, Alessandra Franco, Martin L. Hibberd, Long T. Hoang, Yutaka Kanda, Biswa Choudhury, Adriana H. Tremoulet, John T. Kanegaye, Chisato Shimizu
Publikováno v:
Ogata, S; Shimizu, C; Franco, A; Touma, R; Kanegaye, JT; Choudhury, BP; et al.(2013). Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. PLoS ONE, 8(12). doi: 10.1371/journal.pone.0081448. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/7qj5m85w
PLoS ONE, Vol 8, Iss 12, p e81448 (2013)
PloS one, vol 8, iss 12
PLoS ONE
PLoS ONE, Vol 8, Iss 12, p e81448 (2013)
PloS one, vol 8, iss 12
PLoS ONE
Objectives: Although intravenous immunoglobulin (IVIG) is highly effective in Kawasaki disease (KD), mechanisms are not understood and 10-20% of patients are treatment-resistant, manifesting a higher rate of coronary artery aneurysms. Murine models s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5302cd87afc4fd2145fad75230de36c6
http://www.escholarship.org/uc/item/7qj5m85w
http://www.escholarship.org/uc/item/7qj5m85w
Autor:
Dehnert, Karen W., Baskin, Jeremy M., Laughlin, Scott T., Beahm, Brendan J., Naidu, Natasha N., Amacher, Sharon L., Bertozzi, Carolyn R.
Publikováno v:
ChemBioChem; Feb2012, Vol. 13 Issue 3, p353-357, 5p